Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 43.96
+0.22 (0.50%)
At close: May 26, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 23.13 billion as of May 27, 2026. Its market cap has decreased by -28.19% in one year.
Market Cap
23.13B
Enterprise Value
24.30B
Revenue
18.27B
Ranking
n/a
PE Ratio
24.40
Stock Price
43.96
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 23.13B, an increase of 167.20%. That is a compound annual growth rate of 3.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 24.09B | 7.04% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 33.62B |
| Bliss GVS Pharma | 33.60B |
| Gufic Biosciences | 32.72B |
| Hikal | 26.85B |
| Unichem Laboratories | 25.46B |
| Kwality Pharmaceuticals | 23.14B |
| Amrutanjan Health Care | 16.21B |
| Venus Remedies | 15.20B |